These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 29340587)

  • 1. Subclinical device-detected atrial fibrillation and stroke risk: a systematic review and meta-analysis.
    Mahajan R; Perera T; Elliott AD; Twomey DJ; Kumar S; Munwar DA; Khokhar KB; Thiyagarajah A; Middeldorp ME; Nalliah CJ; Hendriks JML; Kalman JM; Lau DH; Sanders P
    Eur Heart J; 2018 Apr; 39(16):1407-1415. PubMed ID: 29340587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
    Di Cori A; Lilli A; Zucchelli G; Zaca V
    Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
    Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
    Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
    Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
    Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
    Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent ischaemic brain lesions related to atrial high rate episodes in patients with cardiac implantable electronic devices.
    Benezet-Mazuecos J; Rubio JM; Cortés M; Iglesias JA; Calle S; de la Vieja JJ; Quiñones MA; Sanchez-Borque P; de la Cruz E; Espejo A; Farré J
    Europace; 2015 Mar; 17(3):364-9. PubMed ID: 25336664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Incidence of De Novo and Subclinical Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy and Cardiac Rhythm Management Device.
    Wilke I; Witzel K; Münch J; Pecha S; Blankenberg S; Reichenspurner H; Willems S; Patten M; Aydin A
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):779-84. PubMed ID: 27060297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
    Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
    Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
    Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
    Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical atrial fibrillation and the risk of stroke.
    Healey JS; Connolly SJ; Gold MR; Israel CW; Van Gelder IC; Capucci A; Lau CP; Fain E; Yang S; Bailleul C; Morillo CA; Carlson M; Themeles E; Kaufman ES; Hohnloser SH;
    N Engl J Med; 2012 Jan; 366(2):120-9. PubMed ID: 22236222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
    Healey JS; Wong J
    Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
    Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
    Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and prognostic significance of device-detected subclinical atrial fibrillation in patients with heart failure and reduced ejection fraction.
    Zakeri R; Morgan JM; Phillips P; Kitt S; Ng GA; McComb JM; Williams S; Wright DJ; Gill JS; Seed A; Witte KK; Cowie MR;
    Int J Cardiol; 2020 Aug; 312():64-70. PubMed ID: 32169346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review.
    Hess PL; Healey JS; Granger CB; Connolly SJ; Ziegler PD; Alexander JH; Kowey PR; Ruff CT; Flaker G; Halperin JL; Hart RG; Lopes RD
    JAMA Cardiol; 2017 Mar; 2(3):324-331. PubMed ID: 28097334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Doundoulakis I; Gavriilaki M; Tsiachris D; Arsenos P; Antoniou CK; Dimou S; Soulaidopoulos S; Farmakis I; Akrivos E; Stoiloudis P; Notas K; Kimiskidis VK; Giannakoulas G; Paraskevaidis S; Gatzoulis KA; Tsioufis K
    Cardiovasc Drugs Ther; 2022 Oct; 36(5):951-958. PubMed ID: 34089429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tactics of anticoagulant therapy in patients with cardiac implantable electronic devices and subclinical atrial fibrillation: A review].
    Razina TV; Serova MV; Andreev DA; Sazonova YS; Komarova AG
    Ter Arkh; 2023 May; 95(4):472054. PubMed ID: 38158984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual atrial tachyarrhythmia burden determined by device interrogation in patients with cardiac implanted electronic devices is associated with a risk of ischaemic stroke independent of known risk factors.
    Wang SH; Kang YC; Wang CC; Wen MS; Hung KC; Wang CY; Chen TH
    Eur J Cardiothorac Surg; 2015 May; 47(5):840-6. PubMed ID: 24970573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of occult atrial fibrillation by pacemaker interrogation in cryptogenic stroke.
    Moubarak G; Tamazyan R; Garcon P; Join Lambert C; Bruandet M; Cazeau S; Zuber M
    J Interv Card Electrophysiol; 2014 Apr; 39(3):261-5. PubMed ID: 24532115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Device-detected atrial fibrillation: what to do with asymptomatic patients?
    Chen-Scarabelli C; Scarabelli TM; Ellenbogen KA; Halperin JL
    J Am Coll Cardiol; 2015 Jan; 65(3):281-94. PubMed ID: 25614426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stroke incidence in patients with cardiac implantable electronic devices remotely controlled with automatic alerts of atrial fibrillation. A sub-analysis of the HomeGuide study.
    Ricci RP; Vaccari D; Morichelli L; Zanotto G; Calò L; D'Onofrio A; Curnis A; Pisanò EC; Nangah R; Brieda M; Calzolari V; Melissano D; Rovai N; Gargaro A
    Int J Cardiol; 2016 Sep; 219():251-6. PubMed ID: 27340918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.